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Background: As infection with the Human Immunodeficiency Virus (HIV) has evolved to a chronic disease,
perceived health-related quality of life (HRQoL) is becoming a prominent and important patient-reported outcome
measure in HIV care. Literature discusses different factors influencing HRQoL in this population, however, currently
no consensus exists about the main determinants. In this review a clear, up-to-date overview of the determinants
influencing HRQOL among people living with HIV is provided.
Methods: All studies published before July 2013 that identified determinants of HRQoL among people living with
HIV in high-income countries, were considered in this narrative review. PubMed, Web of Science and The Cochrane
Library were consulted using the keywords ‘determinants’, ‘quality of life’, ‘HIV’ and ‘AIDS’. To be included, studies
should have reported overall health and/or physical/mental health scores on a validated instrument and performed
multivariable regression analyses to identify determinants that independently influence perceived HRQoL.
Results: In total, 49 studies were included for further analysis and they used a variety of HRQoL instruments:
Medical Outcomes Study Short Form-36 or variants, Medical Outcomes Study-HIV, HIV Cost and Services Utilization
Study measure, Multidimensional Quality of Life Questionnaire, HIV targeted quality of life instrument, Functional
Assessment of Human Immunodeficiency Virus Infection, HIV Overview of Problems Evaluation System, EuroQol,
Fanning Quality of Life scale, Health Index and PROQOL-HIV. In this review, the discussed determinants were thematically
divided into socio-demographic, clinical, psychological and behavioural factors. Employment, immunological status,
presence of symptoms, depression, social support and adherence to antiretroviral therapy were most frequently and
consistently reported to be associated with HRQoL among people living with HIV.
Conclusions: HRQoL among people living with HIV is influenced by several determinants. These determinants
independently, but simultaneously impact perceived HRQoL. Most HRQoL instruments do not capture all key
determinants. We recommend that the choice for an instrument should depend on the purpose of the
HRQoL assessment.
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Since the HAART (highly active antiretroviral therapy)
era, HIV has been added to the increasing list of chronic
diseases [1,2]. Still, daily and strict intake of antiretroviral
medication is required to achieve or to maintain viro-
logical and immunological control [3,4]. However, these
are not the only outcomes that should be taken into ac-
count. In chronic diseases, assessing health-related quality
of life (HRQoL) has become an integral part of follow-up.
HRQoL measurements provide valuable feedback about
therapeutic interventions and they are indispensable in
cost-effectiveness analyses [5]. HRQoL measures can also
identify determinants of HRQoL among people living with
HIV (PLHIV), which is vital to maximize HRQoL. Al-
though different studies identified factors associated with
HRQoL, there is no consensus about the main determi-
nants. In addition, a variety of HRQoL instruments are
currently being used in PLHIV. In this review, we exam-
ined determinants reported to be associated with HRQoL
in PLHIV and we critically discuss the use of HRQoL
instruments.
Methods
A narrative review was performed. The global search
strategy was to search the databases PubMed, Web of
Science and The Cochrane Library using the (Mesh)
terms ‘determinant(s)’, ‘quality of life’, ‘HIV’, ’AIDS’ as title
words. Articles in this review are 1) investigating HRQoL
in HIV-infected (adult) individuals 2) published prior to
July 2013, 3) full text available in English, 4) conducted in
high-income countries, 5) reporting HRQoL as one total
score and/or as a physical and mental score, 6) using a val-
idated HRQoL instrument and 7) applying quantitative
methodology and multivariable regression analysis to
identify determinants of HRQoL. Titles and abstracts were
reviewed to verify those criteria. If all inclusion criteria
were fulfilled or if this was still unclear, the manuscript
was fully read. In case the full text revealed that not all
requirements were present, the manuscript was still
excluded from further consideration. Additional literature
was obtained through searching references in the manu-
scripts (snowball method).
A priori, a framework with four categories of determi-
nants was made: socio-demographic, clinical, psycho-
logical and behavioural determinants. Those categories
were chosen by analogy with research on HRQoL per-
formed in our hospital department. In particular, our
research assesses three of the categories through a self-
report questionnaire, consisting of a sociodemographic
part, a psychological part (assessment of depressive
symptoms, social support, satisfaction with care) and a
behavioural part (assessment of adherence and sub-
stance use). Clinical parameters on the other hand are
assessed via the electronic patient record [6]. Whilereading and interpreting the manuscripts, the categor-
ies were further subdivided. Results and conclusions
from manuscripts were then allocated to one or more
determinants. The review was further elaborated by
addressing every determinant separately and rereading
all manuscripts that were relevant for that determinant.
In addition to the manuscript, an extensive table is
provided in which methodological features (study design,
sample, instrument) and main results of all included
studies are provided (Additional File 1: Table S1).
Results
In total, 49 studies were included for further analysis.
The instruments used to measure HRQoL were various:
Medical Outcomes Study Short Form-36 or variants,
Medical Outcomes Study-HIV, HIV Cost and Services
Utilization Study measure, Multidimensional Quality of
Life Questionnaire, HIV targeted quality of life instrument,
Functional Assessment of Human Immunodeficiency Virus
Infection, HIV Overview of Problems Evaluation System,
EuroQol, Fanning Quality of Life scale, Health Index and
PROQOL-HIV (Additional File 1: Table S1).
Determinants of HRQoL were divided into four cat-
egories: socio-demographic, clinical, psychological and
behavioural factors. For purposes of intelligibility and
conciseness, only determinants of overall health outcomes,
as well as physical and mental health scores were commen-
ted. Factors associated with subscales of HRQoL were not
discussed.
Socio-demographic characteristics
Gender
There was no general agreement about gender differ-
ences in HRQoL [7]. If differences were found, women
mostly reported lower HRQoL than men [8-10]. Differ-
ent explanations were given: women would be more
likely to report their unfavourable physical states than
men because men are expected to adopt a more stoic
attitude [10,11], items on physical subscales would be
different for men and women [10], and/or women would
have more feelings of guilt [12]. Gender differences in
HRQoL could also be a consequence of gender differ-
ences in mental illnesses. Mood disorders, anxiety disor-
ders and psychosomatic disorders are more prevalent in
females, possibly contributing to the HRQoL difference
[11]. Controlling for clinical and socio-demographic
factors could eliminate gender differences [7].
In contrast, some studies found that females had a bet-
ter mental health [13] or reported better overall health
[14]. Better coping strategies in females and a higher
proportion of anxious men in that sample, respectively,
were proposed as explanations for those findings. At last,
Mrus and colleagues observed no difference towards
overall health change between the genders and they
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may be a better measure to evaluate HRQoL longitu-
dinally [11].
Age
Older age was generally associated with lower physical
health [13,15-19] and with a greater decline in physical
health over time [9] most likely due to physical senes-
cence. The relationship with mental health was less
distinct. There could be a positive relationship between
younger age and better mental health [19] while older
age was associated with a decrease in mental health
after six months in another study [20]. As most studies
were not able to find any association, it seems that mental
health is less age-dependent.
Family situation
A stable relationship conceivably contributes to a good
HRQoL. This was shown, though only for physical health,
in two studies [18,21]. Conflicting results were found with
respect to changes in HRQoL over time. In women, being
single was associated with an improvement in HRQoL
after four months, whereas being married was associated
with a decline [22]. Being chronically ill possibly causes
more health distress and anxiety in married women, since
the illness can interfere with their role as a spouse.
However, a stable partner was also found to be positively
associated with mental health after one year [9].
Concerning parenthood, a similar picture emerged.
Children bring happiness, however, ill parents will be
more worried about their health because of them. PLHIV
may be more confronted with their constraints through
the process of bringing up children [9]. Accordingly, in
two studies, parenthood was negatively associated with
physical health over time [8,9].
Socio-economic status: education, employment, income
There was a joint consent that socio-economic status has
an impact on HRQoL [9,14,15,17,18,20,23-27]. Employment
influenced both physical and mental health status, or over-
all health [14,17,23,24,28] although the effect on physical
health was twice as big [25]. Employment was a positive
predictor for good physical health after three to four years
[26]. Employment constitutes a big part of the daily life of
people. It can provide structure, a social support network,
role identity and meaning [29]. The exact association be-
tween employment and HRQoL, however, remained un-
proven. Probably this is a bi-directional relationship: good
HRQoL could be a requirement to be able to work (selec-
tion hypothesis), or work could be a source of well-being
(causation hypothesis) [25,27].
There were indications for an association between finan-
cial situation and HRQoL [15,18,23]. A low versus middle-
or high income was associated with a lower mental andoverall health [23]. Yet, income may be not the best
measure to assess financial situation. Data concerning
expenditures, family composition, financial insecurity
and financial worries could provide useful additional
information [30].
Education has also been linked to HRQoL and the re-
lationship would be linear (i.e. higher education associ-
ated with higher HRQoL) [23]. An education of less
than five years was negatively associated with mental
health after six months [20] and with physical health
change after 12 months [9]. It is possible that a lower
education is a proxy of a lower socio-economic status
in general, but it could also represent a poorer ability
to understand the therapy recommendations [20]. This
leads to less informed, less involved and less empowered
patients which affects their HRQoL [31,32].
Clinical and disease-related factors
Virological and immunological status
A better virological status was associated with a better
overall [33], physical [14,18,34] and mental health [14],
although a reasonable amount of studies did not find an
(independent) association [8,13,15,20,27].
On the other hand, the relationship between immuno-
logical status and HRQoL was better corroborated by
scientific evidence: a higher CD4-cell count was associ-
ated with a better physical health [15,16,20,21,34,35]. It
was also a predictor for better physical health scores on
follow-up measurements [20,36,37]. However, physical
health improved more in patients who started ART at
CD4 <200 cells/μl than in patients with 200–350 cells/μl
or >350 cells/μl, because their physical health at base-
line was worse [38]. Current guidelines recommend
nonetheless to start ART early (i.e. 350–500 celles/μl),
because there is evidence that this results in reduced
progression to AIDS and reduced mortality [39]. In an-
other study, CD4-count was negatively associated with
HRQoL at baseline, but positively after 12 months [40].
It is possible that PLHIV with a high CD4-count at base-
line wanted to go back to their excellent health and there-
fore considered their actual health status as dissatisfying.
Over time, PLHIV develop other perceptions and expecta-
tions about HRQoL and may consider their health status
acceptable [40].
Three studies have found an additional relationship
with mental health. A lower CD4 cell count was then as-
sociated with a lower mental health score (MHS) (cross-
sectional and at 12 months) [9,18,35]. This could be due
to the faster disease progression in PLHIV with low CD4-
counts, leading to distress [9].
Staging and time since diagnosis
Regarding disease stage, a clear effect on physical health
has been established: as HIV evolves to a further stage,
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is seen in people with AIDS [18,23,25] and AIDS nega-
tively influenced future physical health in follow-up stud-
ies [9,26,36]. In contrast, the effects on mental health were
variable. A longer time since diagnosis was associated with
both lower [14] and higher mental health [25]. A lower
mental health over time could arise in cases where longi-
tudinal follow-up resulted in a successful control of HIV.
PLHIV may then experience difficulties to report mental
problems because they are expected to feel fortunate be-
cause of their good health [14]. On the other hand, a lon-
ger duration could facilitate the development of effective
coping strategies which could enhance mental health [40].
For health care providers, it is important to monitor
mental health continuously, irrespective of the physical
condition of the patient.ART
The effect of ART on HRQoL has been described as a
balance between reduced HIV-related symptoms and
better life-expectancy on the one hand and medication
side-effects on the other hand [41]. In people with an
acceptable health status prior to ART-initiation, these
side-effects could even overrule the benefits [21]. En-
countering few ART-related side-effects contributed to
normal physical and mental health [21]. Sexual dysfunc-
tion is an example of a side-effect – although frequently
seen without iatrogenic cause – which was found to
have a significant impact on HRQoL [42].
Recent studies mainly showed a positive effect of ART
on HRQoL. This could be due to the continuous
improvements in ART leading to less side-effects and to
possibilities of combination preparations [43,44]. ART
treatment was independently associated with a higher
physical health [17] and interruption of ART treatment
was associated with lower mental health [15]. In some
studies, no HRQoL-differences between ART-treated
and non-treated PLHIV were observed [8,14,18], or only
at bivariate level [20]. Maybe non-treated PLHIV had a
better health, through which treatment was (still) not
required [14].Presence of symptoms
The negative influence of HIV-related symptoms on
HRQoL was supported by scientific evidence and gener-
ally, a relationship with both physical and mental health
was found [20,23,25,26,28,45,46]. Long-term studies found
the same results [9,36]. In the HIV Cost and Services Util-
isation Study, there was an inverse linear relation between
number of symptoms and SF-36 scores. Each additional
symptom (out of 13), was associated with a nearly
1.5-point decrease in physical and mental health [23].
Furthermore, symptom status was a stronger predictor forHRQoL than functional status, health perceptions, age,
sex, biological and physiological markers [47].
Lipodystrophy was found to be an influential HIV-
related symptom [48]. It affected both physical and mental
health [48] and was associated with lower mental health
after one year [9]. In time trade-off preference measure-
ments, PLHIV would even give up a life year to avoid lipo-
dystrophy [49]. It was although possible that HRQoL was
affected only in PLHIV perceiving a moderate to severe
body alteration [50]. Lipodystrophy is a highly visible
symptom, and it could also affect the self-esteem and
social contacts of PLHIV [48]. Similar negative effects of
weight loss have been reported [14].
Comorbidity
A negative effect of comorbidity burden on HRQoL, espe-
cially on physical health, was supported by cross-sectional
studies [15,51] and a longitudinal study [40]. Regarding
specific comorbidity, comorbid hepatitis B was associated
with a lower physical health and hepatitis C negatively in-
fluenced physical health after one year [9]. On the other
hand, HRQoL was the same among PLHIV, people in-
fected with hepatitis C and people infected with both HIV
and hepatitis C [17]. PLHIV with a GB virus C infection
reported even a better quality of life than PLHIV without
GB virus C infection [52]. Authors reasoned that patients’
HRQoL could be more affected by socio-economic and
psychological factors than physical illnesses as HIV or
hepatitis C, as the latter have become manageable diseases
[17], or they may be a more favourable course of HIV
infection in patients with GB virus C infection [52].
Psychological factors
Depression and anxiety
Depression strongly interferes with daily life and the nega-
tive impact on HRQoL was obvious [8,46,53,54]. Some au-
thors did only find an association with mental health, and
not with physical health [9,15,16,55] although depression
can also cause physical problems (e.g. less appetite, sleep
disorders…). Not only the presence, but also a history of
depression was associated with poorer HRQoL [17]. De-
pression also mediated the relationships between coping
styles, social support and HRQoL [16,53], which will be
discussed further on. The prevalence of anxiety disorders
in PLHIV is higher than in the general population and it is
known that anxiety is associated with depressive symp-
toms [14,56]. Anxiety was found to be associated with a
diminished physical and mental health [18].
Coping styles, locus of control and religion
Coping styles are highly relevant in PLHIV, looking for
example at the stress resulting from HIV diagnosis and
treatment as well as multiple possible other stressors
[53,57]. Studies examining the effect of coping styles on
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namely via the intermediate determinant depression
[16,53]. An active coping style has also been found to be
directly associated with a better HRQoL [35,40]. People
adopting an active coping style undertake actions to en-
hance their current state and this coping style is gener-
ally thought to be effective in reducing stress [58] and
the impact of life stressors on mental health [19]. Coping
styles are also associated with health locus of control
(HLOC). People with an internal HLOC believe that
health outcomes result directly from one’s own behav-
iour whereas people with an external HLOC believe that
others– other persons, fate, or luck– determine the out-
come [59]. An internal HLOC was a predictor of a better
physical health and a powerful others HLOC predicted a
lower mental health [26]. However, somewhat contrary
to that, a higher level of spirituality/religion (which
could be associated with an external HLOC) has been
found to be correlated with the perception of a better
life then before the HIV diagnosis. It seems that reli-
gious/spiritual coping could also be an effective coping
style [60]. Nevertheless, religious coping could be
ineffective too, by arousing feelings of punishment by
God, or being ostracised [61].
Social support
Social support could directly influence health outcomes,
or it could serve as a buffer to reduce the influence of
stressors on health outcomes [62]. Many studies have
found positive relations between the presence of social
support and both physical and mental health [13,25,53].
Furthermore, a higher social support at baseline was pre-
dictive for a better mental health after 12 months [40].
In the study of Jia et al. [53], social support had a mainly
indirect role in HRQoL, mediated by depression. This
suggests that enhancing social support could reduce de-
pressive symptoms, which then could improve HRQoL.
It seemed that the more people PLHIV have to talk to
(i.e. providing social support), the better the mental
health was [15]. By studying different types of social sup-
port (emotional and tangible social support), Friedland
et al. were able to distinguish different patterns [63].
Emotional social support (e.g. empathy, affection, caring)
positively influenced HRQoL and tangible social support
(e.g. financial and material assistance) negatively influ-
enced HRQoL. People who received more tangible social
support perceived themselves as more ill and as having a
lower HRQoL [63]. Associations between social support
and HRQoL over time seemed to vary. Possibly, social
support becomes more important at difficult times [64].
Neuropsychological status
Cognitive problems lead to difficulties in every day
practices, such as remembering names of new people,concentrating during a conversation or finding solutions
for unexpected problems [65]. These will most probably
affect HRQoL. In a study in HIV positive women, neuro-
cognitive performance together with emotional distress
accounted for most of the variance of HRQoL [66]. The
validation study of the Quality of Well-being scale for
HIV patients also revealed a significant influence of neu-
rocognitive impairment [54]. In another study, neurocog-
nitive impairment reduced physical health, but not mental
health [55].
Other (health care, disclosure, stigma)
The way PLHIV perceive health care service has shown
to be important for the patient’s HRQoL [18,20]. Poor
satisfaction with information from health care providers
was independently associated with a lower mental health
[20]. Inadequate communication with the physician
could lead to misunderstanding, uncertainty and a lack
of trust in the caregiver [20]. Therefore, communication
is considered one of the core competencies of physicians
[67]. Some PLHIV even experience rejection by the med-
ical staff, especially people infected through drug use.
Wrong attitudes could hinder a good physician-patient re-
lationship, which is crucial for physical HRQoL [18]. Ex-
periencing stigma negatively influenced HRQoL [28] and
discrimination from family, friends or at work negatively
influenced mental health [18]. Disclosing seropositive sta-
tus was found to have negative effects on both physical
and mental health [18]. The latter relationship, however,
remained unclear, because disclosure could also be benefi-
cial for the patient’s mental and physical health (mainly
through social support) [68]. However it could potentially
be related to the fact that people with worse HRQoL have
to disclose their seropositive status because of the symp-
toms, and may feel forced to do so instead of voluntarily
doing so. PLHIV should be prepared and supported by
health care professionals before their decision whether or
not to disclose and before they are confronted with stigma
and discrimination, in order to be able to better cope with
these difficulties [46].
Behavioural factors
Smoking
The relationships between smoking and HRQoL was not
extensively studied yet [69]. Two studies suggested that
smoking negatively influenced HRQoL [16,69]. Among
HIV-positive veterans, current smokers had the lowest
HRQoL as compared to former and never smokers [69].
Current smokers were more at risk for pulmonary dis-
eases and respiratory symptoms, which may affect their
physical health [69]. However, smoking was also found
to be negatively associated with mental health [16].
Psychiatric comorbidity was found to be highly prevalent
in smokers – or the other way around, since patients
Table 1 Overview of HRQoL instruments used in the
reviewed manuscripts
Name of the instrument Generic or
HIV-specific
instrument
Measurements
SF-36 (Medical Outcomes
Study Short Form-36 or
variants (SF-12, SF-8)) [88]
Generic 8 subscales
Physical health
summary
Mental health summary
MOS-HIV (Medical
Outcomes Study-HIV) [89]
HIV-specific 11 subscales
Physical health score
Mental health score
HCSUS (HIV Cost and Services
Utilization Study tool) [90]
HIV-specific 10 subscales
Physical health
Mental health
Overall health
MQoL-HIV (Multidimensional
Quality of Life Questionnaire
for people with HIV/AIDS) [91]
HIV-specific 10 subscales
Global score
HAT-QOL (HIV targeted
quality of life instrument) [92]
HIV-specific 9 subscales
Global score
FAHI (Functional Assessment
of Human Immunodeficiency
Virus Infection) [93]
HIV-specific 4 subscales:
Physical well-being
Emotional well-being
(Social well-being)*
(Functional well-being)*
HOPES (HIV Overview
of Problems Evaluation
System) [94]
HIV-specific 6 subscales
Global score
EQ (EuroQol) [95] Generic Global score (utility)
Fanning Quality of Life
Scale [96]
HIV-specific Global score
HI (Health Index) [97,98] Generic Physical well-being
Mental well-being
PROQOL [99] HIV-specific 7 subscales
(+ 1 on treatment impact)
Global score
*Determinants of the FAHI-subscales ‘social well-being’ and ‘functional well-being’
were not considered in this review.
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symptoms and anxiety [70].
Alcohol use
The effect of alcohol use on HRQoL in PLHIV was scarcely
or only superficially studied [71]. In none of those stud-
ies among PLHIV, an independent association between
alcohol use and HRQoL was found [8,18,71] except for
one. In that study, not using alcohol was a predictor for
a lower physical health [15]. A causal relationship
between light to moderate alcohol use and a better
physical HRQoL is, however, not very plausible. Light to
moderate alcohol use could rather be seen as an expres-
sion of risk behaviour for which a certain degree of
functional status is required [15].
Drug use
Quality of life in HIV-positive drug users has been rela-
tively more studied than in tobacco and alcohol users,
because IDU is a risk factor for HIV-transmission.
Current drug use was associated with lower mental
health [15,71,72]. HRQoL in former users of illicit
drugs was not worse than in persons who never used
drugs [71]. For IDU the same was found: being an IDU
was associated with a lower physical health [13],
whereas being a former IDU was associated with a bet-
ter physical and mental health [21]. Impact of drug use
on HRQoL could be direct, via the physical deterioration
caused by the drugs [13] or indirect, via associated psychi-
atric disorders [72].
Adherence
In a review of twelve studies considering the relationship
between adherence to ART and HRQoL, ten showed an
association with HRQoL [73]. Three of them applied a
prospective design and were thus more indicative for a
causal relationship [73]. More adherent PLHIV probably
had better virological and immunological outcomes and
could therefore have a better HRQoL.
Reporting concerns and difficulties about taking medi-
cation, was associated with poor mental health [13,74].
These difficulties could originate in a low self-efficacy, a
high pill burden, difficulties to incorporate the medication
moments in daily activities, experiencing side-effects…
Life style and sexual risk behaviour
Not surprisingly, physical activity was associated with a
better physical health [16,75,76]. Healthy nutrition and a
good stress management were associated with both phys-
ical and mental health [75]. Associations between unsafe
sex and HRQoL were contradictory: in one study, there
was no relationship to either physical or mental health
and in another study [75], having unsafe sex with casual
partners was associated with poor mental health [77].Discussion
This review presents an overview of socio-demographic,
clinical, psychological and behavioural factors associated
with HRQoL in PLHIV. Many determinants have been
found, and it is not clear which determinants are the
strongest predictors for HRQoL. Nonetheless, there seems
to be a consensus about the effect of socio-economic status,
immunological status, presence of symptoms, (psychiatric)
comorbidity, social support and adherence to ART.
These partly correspond to determinants of HRQoL of
people living with other diseases. In patients with Crohn’s
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subarachnoid haemorrhage, advanced disease stage
(cfr. immunological status) was found to be predictive
for impaired HRQoL [78-81]. Disability (cfr. presence
of symptoms) was a determinant of HRQoL in patients
with Crohn’s disease, Parkinson’s disease and aneurysmal
subarachnoid haemorrhage [78-80]. Depression was nega-
tively associated with HRQoL in patients with epilepsy,
Parkinson’s disease and aneurysmal subarachnoid haemor-
rhage [79-81]. Presence of comorbidities was associated
with lower HRQoL in patients with epilepsy, lung cancer
and in long-term survivors of colorectal cancer [81-83].
Literature about HRQoL in PLHIV consisted mostly of
cross-sectional studies, however some longitudinal and
interventional studies were found as well. Overall, there
was a great diversity of instruments to measure HRQoL
in PLHIV. Both generic (regularly SF-36) and disease-
specific (MOS-HIV, HCSUS, HAT-QOL …) instruments
were used (see Table 1). It is impossible to point out the
best HRQoL instrument for PLHIV, since that choice
mainly depends on the purpose of the assessment. For
example, cost-effectiveness analyses require a HRQoL
instrument that provides an index score while clinical
routine management requires an instrument that pro-
vides information about HIV-specific aspects influen-
cing HRQoL in PLHIV. Up till now, however, many
HIV-specific instruments omit some of those aspects
(e.g. stigma, coping and resilience, body image…) and
literature concerning those determinants is rather scarce
[35,84,85]. Instruments developed in cooperation with
PLHIV (e.g. FAHI, HAT-QOL, HOPES, PROQOL) try
to minimize that limitation. HRQoL instruments in
PLHIV have been compared and discussed by many re-
searchers, mainly by means of two-by-two comparisons in
a selected population. Two studies provide a more general
overview: Clayson et al. brought three generic (SF-36,
EuroQol and Health Utilities Index) and two HIV-specific
(MOS-HIV and FAHI) instruments forward as appropriate
for use in clinical trials [86]. Their conclusions were based
upon assessment of content, practicality and psychometric
properties. Following their criteria, generic instruments
should also be able to provide preference-based index
scores and they should have normative population data.
Grossman et al. suggest the SF-12 and MOS-HIV as the
most appropriate tools [87]. They made a trade-off
between the brevity of the instrument and the usefulness
of the information provided.
The heterogeneity of HRQoL instruments was also
present in the types and numbers of possible determi-
nants that were analysed. Moreover, the detail by which
these determinants were studied, varied from one single
question to a whole battery of tests and interviews. Al-
though this makes it difficult to compare results, it per-
mits to 1) state that a certain factor is associated withHRQoL, independently of many other variables and 2)
describe this effect more profoundly.
This is a narrative review, and this method has several
limitations. The literature search was not integrally
documented, and is as such impossible to reproduce and
the inclusion of the studies could be subject to personal
bias. Nonetheless, we reported transparently about the
search method and aimed at composing a review as
complete and as consistent as possible. The latter is also
the reason for including only papers that used quantita-
tive, multivariable regression analyses. Thereby, we do
not want to detract from the great value of papers using
other methodologies (especially qualitative research).
Conclusion
HRQoL in PLHIV is influenced by many concurrent fac-
tors. From the evidence studied here we can conclude that
there is a consensus about the influence of socio-economic
status, immunological status, presence of symptoms,
(psychiatric) comorbidity, social support and adherence to
ART. Various instruments can be used to assess HRQoL
in PLHIV, however, all have limitations. The choice of
instrument should depend on the purpose of the HRQoL
assessment.
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